Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Medicine, Clostridium difficile, Internal medicine, Epidemiology, Health care, and Intensive care medicine.
Recommendations to Improve Quality of Probiotic Systematic Reviews With Meta-Analyses
Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of <i>Clostridioides difficile</i> Infection in Adults
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple <i>Clostridioides difficile</i> Infection Recurrences
Fecal microbiota transplantation (FMT) for C. difficile infection, just say ‘No’
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
Effectiveness of Probiotic for Primary Prevention of <i>Clostridium difficile</i> Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors
Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027
Pathway to Prevention of Nosocomial Clostridium difficile Infection
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder
Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
Is primary prevention of Clostridium difficile infection possible with specific probiotics?